Literature DB >> 19747121

The p38alpha kinase plays a central role in inflammation.

Gary L Schieven1.   

Abstract

The p38 kinase plays a central role in inflammation, and it has been the subject of extensive efforts in both basic research and drug discovery. This review summarizes the biology of the p38 kinase with a focus on its role in inflammation. The p38 kinase regulates the production of key inflammatory mediators by cells of the innate immune system, including TNFalpha, IL-1beta, and COX-2. In addition, p38 also acts downstream of cytokines such as TNFalpha, mediating some of their effects. Recently p38 has also been found to play a role in responses of T cells, including Th17 and regulatory T cells. Consistent with its important role in inflammation, recent evidence suggests cells may utilize a variety of feedback mechanisms to regulate and maintain p38 signal transduction. The biological processes regulated by p38 kinase suggest both a wide variety of potential indications for inhibitors and a level of complexity that has proven challenging to drug discovery efforts around this target.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747121     DOI: 10.2174/156802609789630974

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  49 in total

1.  Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling.

Authors:  Amy Jo Galliher-Beckley; Jason Grant Williams; John Anthony Cidlowski
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  Genetic evidence for critical roles of P38α protein in regulating mast cell differentiation and chemotaxis through distinct mechanisms.

Authors:  Ping Hu; Nadia Carlesso; Mingjiang Xu; Yan Liu; Angel R Nebreda; Clifford Takemoto; Reuben Kapur
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

3.  Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.

Authors:  Gipsy Majumdar; Robert J Rooney; I Maria Johnson; Rajendra Raghow
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

4.  The p38 MAP Kinase Family as Regulators of Proinflammatory Cytokine Production in Degenerative Diseases of the CNS.

Authors:  Adam D Bachstetter; Linda J Van Eldik
Journal:  Aging Dis       Date:  2010-09-24       Impact factor: 6.745

5.  A muscle-specific p38 MAPK/Mef2/MnSOD pathway regulates stress, motor function, and life span in Drosophila.

Authors:  Alysia Vrailas-Mortimer; Tania del Rivero; Subhas Mukherjee; Sanjay Nag; Alexandros Gaitanidis; Dimitris Kadas; Christos Consoulas; Atanu Duttaroy; Subhabrata Sanyal
Journal:  Dev Cell       Date:  2011-10-18       Impact factor: 12.270

6.  Leukemia Inhibitory Factor Represses GnRH Gene Expression via cFOS during Inflammation in Male Mice.

Authors:  Nancy M Lainez; Djurdjica Coss
Journal:  Neuroendocrinology       Date:  2019-01-10       Impact factor: 4.914

Review 7.  Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.

Authors:  Mohammad Salem; Jakob Benedict Seidelin; Gerhard Rogler; Ole Haagen Nielsen
Journal:  Cell Mol Life Sci       Date:  2012-12-29       Impact factor: 9.261

8.  Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells.

Authors:  Joshua C Johnson; Osvaldo Martinez; Anna N Honko; Lisa E Hensley; Gene G Olinger; Christopher F Basler
Journal:  Antiviral Res       Date:  2014-05-09       Impact factor: 5.970

9.  Population pharmacokinetics of losmapimod in healthy subjects and patients with rheumatoid arthritis and chronic obstructive pulmonary diseases.

Authors:  Shuying Yang; Pauline Lukey; Misba Beerahee; Frank Hoke
Journal:  Clin Pharmacokinet       Date:  2013-03       Impact factor: 6.447

10.  First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes.

Authors:  Zeynep Yurtsever; Dhara A Patel; Daniel L Kober; Alvin Su; Chantel A Miller; Arthur G Romero; Michael J Holtzman; Tom J Brett
Journal:  Biochim Biophys Acta       Date:  2016-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.